Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset

Multiple Sclerosis Journal

Volumn 20, Issue 8, 2014, Pages 1086-1094

  Collongues, N ^a   Marignier, R ^b   Jacob, A ^c   Leite, M I ^d   Siva, A ^e   Paul, F ^f   Zephir, H ^g   Akman Demir, G ^e   Elsone, L ^c   Jarius, S ^h   Papeix, C ⁱ   Mutch, K ^c   Saip, S ^e   Wildemann, B ^h   Kitley, J ^d   Karabudak, R ^j   Aktas, O ^k   Kuscu, D ^l   Altintas, A ^e   Palace, J ^d   Confavreux, C ^m   De Seze, J ^a   more..

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITÉ DE LYON   (France)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ISTANBUL UNIVERSITY   (Turkey)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g LILLE UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j HACETTEPE UNIVERSITY   (Turkey)

^k HEINRICH HEINE UNIVERSITY   (Germany)

^l Bakirkoy Hospital for Psychiatric and Neurological Diseases   (Turkey)

^m NONE

more..

Author keywords

Aging; aquaporin antibody; aquaporin 4; late onset; morbidity; mortality; neuromyelitis optica; prognosis; spectrum disorders

Indexed keywords

AQUAPORIN 4 ANTIBODY; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEATH; DISABILITY; DISEASE SEVERITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FRANCE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; MYELOOPTIC NEUROPATHY; NEUROMYELITIS OPTICA SPECTRUM DISORDER; ONSET AGE; OPPORTUNISTIC INFECTION; TURKEY (REPUBLIC); UNITED KINGDOM; VISION; BLOOD; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; DISEASE EXACERBATION; EPIDEMIOLOGY; EUROPE; IMMUNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR; VERY ELDERLY; ACUTE MYELITIS; CAUCASIAN; CLINICAL FEATURE; FOLLOW UP; LATE ONSET DISORDER; MYELITIS; PREDICTOR VARIABLE; RELAPSE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; AQUAPORIN 4; AUTOANTIBODIES; BIOMARKERS; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DISABILITY EVALUATION; DISEASE PROGRESSION; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; NEUROMYELITIS OPTICA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84904789819     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513515085     Document Type: Article

References (29)

1. Akman-Demir G, Tuzun E, Waters P, et al. Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol. 2011 ; 258: 464-470
2. Collongues N, Marignier R, Zephir H, et al. Neuromyelitis optica in France: A multicenter study of 125 patients. Neurology. 2010 ; 74: 736-742
3. Jarius S, Ruprecht K, Wildemann B, et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. J Neuroinflammation. 2012 ; 9: 14
4. Kira J. Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: Astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci. 2011 ; 311: 69-77
5. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112 (Pubitemid 39626806)
6. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815 (Pubitemid 47238676)
7. Waters P, Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: Current status of the assays. MS Forum. 2008 ; 15: 99-105
8. Takahashi T, Fujihara K, Nakashima I, et al. Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med. 2006 ; 210: 307-313 (Pubitemid 44883971)
9. Kitley J, Leite MI, Nakashima I, et al. Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain. 2012 ; 135: 1834-1849
10. Collongues N, Marignier R, Zephir H, et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology. 2010 ; 75: 1084-1088
11. Lotze TE, Northrop JL, Hutton GJ, et al. Spectrum of pediatric neuromyelitis optica. Pediatrics. 2008 ; 122: 1039-1047
12. Banwell B, Tenembaum S, Lennon VA, et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology. 2008 ; 70: 344-352 (Pubitemid 351653396)
13. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology. 2008 ; 71: 93-100
14. Nagaishi A, Takagi M, Umemura A, et al. Clinical features of neuromyelitis optica in a large Japanese cohort: Comparison between phenotypes. J Neurol Neurosurg Psychiatry. 2011 ; 82: 1360-1364
15. Filley CM, Sternberg PE, Norenberg MD. Neuromyelitis optica in the elderly. Arch Neurol. 1984 ; 41: 670-672 (Pubitemid 14108779)
16. Lefaucheur R, Bourre B, Ahtoy P, et al. Neuromyelitis optica with very late onset. J Am Geriatr Soc. 2011 ; 59: 1138-1140
17. Yamakawa K, Kuroda H, Fujihara K, et al. Familial neuromyelitis optica (Devic's syndrome) with late onset in Japan. Neurology. 2000 ; 55: 318-320 (Pubitemid 30604647)
18. Staugaitis SM, Roberts JK, Sacco RL, et al. Devic type multiple sclerosis in an 81 year old woman. J Neurol Neurosurg Psychiatry. 1998 ; 64: 417-418 (Pubitemid 28159867)
19. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489 (Pubitemid 43958540)
20. Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS Med. 2007 ; 4: e133
21. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997 ; 120: 2059-2069 (Pubitemid 27493740)
22. Bender BS. Infectious disease risk in the elderly. Immunol Allergy Clin North Am. 2003 ; 23: 57-64 (Pubitemid 36268304)
23. Nikolich-Zugich J, Rudd BD. Immune memory and aging: An infinite or finite resource . Curr Opin Immunol. 2010 ; 22: 535-540
24. Wingerchuk DM, Pittock SJ, Lucchinetti CF, et al. A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology. 2007 ; 68: 603-605
25. Cabre P, Gonzalez-Quevedo A, Bonnan M, et al. Relapsing neuromyelitis optica: Long term history and clinical predictors of death. J Neurol Neurosurg Psychiatry. 2009 ; 80: 1162-1164
26. Collongues N, Cabre P, Marignier R, et al. A benign form of neuromyelitis optica: Does it exist . Arch Neurol. 2011 ; 68: 918-924
27. Quek AM, McKeon A, Lennon VA, et al. Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol. 2012 ; 69: 1039-1043
28. Marignier R, Bernard-Valnet R, Giraudon P, et al. Aquaporin-4 antibody-negative neuromyelitis optica: Distinct assay sensitivity-dependent entity. Neurology. 2013 ; 80: 2194-2200
29. Jiao Y, Fryer JP, Lennon VA, et al. Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology. 2013 ; 81: 1197-1204